Deranged sodium to sudden death

Journal of Physiology

Volumn 593, Issue 6, 2015, Pages 1331-1345

  Clancy, Colleen E ^a   Chen Izu, Ye ^a   Bers, Donald M ^a   Belardinelli, Luiz ^b   Boyden, Penelope A ^c   Csernoch, Laszlo ^d   Despa, Sanda ^e   Fermini, Bernard ^f   Hool, Livia C ^g   Izu, Leighton ^a   Kass, Robert S ^c   Lederer, W Jonathan ^h   Louch, William E ^i,j   Maack, Christoph ^k   Matiazzi, Alicia ^l   Qu, Zhilin ^m   Rajamani, Sridharan ^b   Rippinger, Crystal M ^a   Sejersted, Ole M ^i,j   O'Rourke, Brian ⁿ   Weiss, James N ^m   Varró, András ^o   Zaza, Antonio ^p   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Gilead Sciences   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e UNIVERSITY OF KENTUCKY   (United States)

^f PFIZER INC   (United States)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

ⁱ ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^j UNIVERSITY OF OSLO   (Norway)

^k SAARLAND UNIVERSITY   (Germany)

^l FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF SZEGED   (Hungary)

^p UNIVERSITY OF MILANO BICOCCA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTIARRHYTHMIC AGENT; CALCIUM; FLECAINIDE; PLACEBO; RANOLAZINE; SODIUM; SODIUM CHANNEL; SODIUM ION;

ARRHYTHMOGENESIS; ARTICLE; CALCIUM BALANCE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DRUG CONTROL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; ENERGY TRANSFER; HEART ARRHYTHMIA; HEART MUSCLE EXCITABILITY; HEART MUSCLE METABOLISM; HUMAN; NONHUMAN; OXIDATIVE STRESS; PERSONALIZED MEDICINE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SODIUM BALANCE; SODIUM CALCIUM EXCHANGE; SODIUM METABOLISM; SUDDEN CARDIAC DEATH; SUDDEN DEATH; ANIMAL; BRUGADA SYNDROME; HEART ARREST; METABOLISM; ORGANIZATION; PATHOPHYSIOLOGY;

ANIMALS; BRUGADA SYNDROME; CONGRESSES AS TOPIC; HEART ARREST; HUMANS; SODIUM;

EID: 84924559521     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2014.281204     Document Type: Article

References (139)

1. Abramson D, Bernabeu MO, Bethwaite B, Burrage K, Corrias A, Enticott C, Garic S, Gavaghan D, Peachey T, Pitt-Francis J, Pueyo E, Rodriguez B, Sher A & Tan J (2010). High-throughput cardiac science on the Grid. Philos Trans A Math Phys Eng Sci 368, 3907-3923.
2. Abu-Zeitone A, Peterson DR, Polonsky B, McNitt S & Moss AJ (2014). Oral contraceptive use and the risk of cardiac events in patients with long QT syndrome. Heart Rhythm 11, 1170-1175.
3. Agarwal SR, MacDougall DA, Tyser R, Pugh SD, Calaghan SC & Harvey RD (2011). Effects of cholesterol depletion on compartmentalized cAMP responses in adult cardiac myocytes. J Mol Cell Cardiol 50, 500-509.
4. Agarwal SR, Yang PC, Rice M, Singer CA, Nikolaev VO, Lohse MJ, Clancy CE & Harvey RD (2014). Role of membrane microdomains in compartmentation of cAMP signaling. PLoS One 9, e95835.
5. 2+ currents in myocytes surviving in the epicardial border zone of the 5-day infarcted canine heart. Circ Res 77, 1180-1191.
6. Ahrens-Nicklas RC, Clancy CE & Christini DJ (2009). Re-evaluating the efficacy of β-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling. Cardiovasc Res 82, 439-447.
7. Allen PD, Schmidt TA, Marsh JD & Kjeldsen K (1992). Na, K-ATPase expression in normal and failing human left ventricle. Basic Res Cardiol 87 (Suppl. 1), 87-94.
8. Allessie MA, Bonke FI & Schopman FJ (1973). Circus movement in rabbit atrial muscle as a mechanism of trachycardia. Circ Res 33, 54-62.
9. Antzelevitch C, Burashnikov A, Sicouri S & Belardinelli L (2011). Electrophysiologic basis for the antiarrhythmic actions of ranolazine. Heart Rhythm 8, 1281-1290.
10. Avkiran M (2003). Basic biology and pharmacology of the cardiac sarcolemmal sodium/hydrogen exchanger. J Card Surg 18 (Suppl. 1), 3-12.
11. i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res 57, 1015-1024.
12. Baba S, Dun W, Cabo C & Boyden PA (2005). Remodeling in cells from different regions of the reentrant circuit during ventricular tachycardia. Circulation 112, 2386-2396.
13. Baetz D, Bernard M, Pinet C, Tamareille S, Chattou S, El Banani H, Coulombe A & Feuvray D (2003). Different pathways for sodium entry in cardiac cells during ischemia and early reperfusion. Mol Cell Biochem 242, 115-120.
14. + and cardiac metabolism. J Mol Cell Cardiol 61, 20-27.
15. Bayes de Luna A, Coumel P & Leclercq JF (1989). Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117, 151-159.
16. Belardinelli L, Liu G, Smith-Maxwell C, Wang WQ, El-Bizri N, Hirakawa R, Karpinski S, Li CH, Hu L, Li XJ, Crumb W, Wu L, Koltun D, Zablocki J, Yao L, Dhalla AK, Rajamani S & Shryock JC (2013). A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. J Pharmacol Exp Ther 344, 23-32.
17. Belardinelli L, Shryock JC & Fraser H (2006). Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92 (Suppl. 4), iv6-iv14.
18. Bennett PB, Yazawa K, Makita N & George AL Jr (1995). Molecular mechanism for an inherited cardiac arrhythmia. Nature 376, 683-685.
19. Bernabeu MO, Bordas R, Pathmanathan P, Pitt-Francis J, Cooper J, Garny A, Gavaghan DJ, Rodriguez B, Southern JA & Whiteley JP (2009). CHASTE: incorporating a novel multi-scale spatial and temporal algorithm into a large-scale open source library. Philos Trans A Math Phys Eng Sci 367, 1907-1930.
20. + regulation in cardiac myocytes. Cardiovasc Res 57, 897-912.
21. Bett GC, Kaplan AD, Lis A, Cimato TR, Tzanakakis ES, Zhou Q, Morales MJ & Rasmusson RL (2013). Electronic 'expression' of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. Heart Rhythm 10, 1903-1910.
22. Blaustein MP & Lederer WJ (1999). Sodium/calcium exchange: its physiological implications. Physiol Rev 79, 763-854.
23. Boink GJ, Lau DH, Shlapakova IN, Sosunov EA, Anyukhovsky EP, Driessen HE, Dun W, Chen M, Danilo P Jr, Rosen TS, Ozgen N, Duffy HS, Kryukova Y, Boyden PA, Robinson RB, Brink PR, Cohen IS & Rosen MR (2012). SkM1 and Cx32 improve conduction in canine myocardial infarcts yet only SkM1 is antiarrhythmic. Cardiovasc Res 94, 450-459.
24. Bossuyt J, Ai X, Moorman JR, Pogwizd SM & Bers DM (2005). Expression and phosphorylation of the Na-pump regulatory subunit phospholemman in heart failure. Circ Res 97, 558-565.
25. Boutjdir M & el-Sherif N ( 1991). Pharmacological evaluation of early afterdepolarisations induced by sea anemone toxin (ATXII) in dog heart. Cardiovasc Res 25, 815-819.
26. Braam SR, Tertoolen L, van de Stolpe A, Meyer T, Passier R & Mummery CL (2010). Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 4, 107-116.
27. Bradley C, Bowery A, Britten R, Budelmann V, Camara O, Christie R, Cookson A, Frangi AF, Gamage TB, Heidlauf T, Krittian S, Ladd D, Little C, Mithraratne K, Nash M, Nickerson D, Nielsen P, Nordbo O, Omholt S, Pashaei A, Paterson D, Rajagopal V, Reeve A, Rohrle O, Safaei S, Sebastian R, Steghofer M, Wu T, Yu T, Zhang HY & Hunter P (2011). OpenCMISS: A multi-physics & multi-scale computational infrastructure for the VPH/Physiome project. Prog Biophys Mol Biol 107, 32-47.
28. Cabo C & Boyden PA (2003). Electrical remodeling of the epicardial border zone in the canine infarcted heart: a computational analysis. Am J Physiol Heart Circ Physiol 284, H372-H384.
29. Cardona K, Trenor B, Molto G, Martinez M, Ferrero JM Jr, Starmer F & Saiz J (2010). Exploring the role of pH in modulating the effects of lidocaine in virtual ischemic tissue. Am J Physiol Heart Circ Physiol 299, H1615-H1624.
30. CAST (1989). Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 321, 406-412.
31. Chen A, Lieu DK, Freschauf L, Lew V, Sharma H, Wang J, Nguyen D, Karakikes I, Hajjar RJ, Gopinathan A, Botvinick E, Fowlkes CC, Li RA & Khine M (2011). Shrink-film configurable multiscale wrinkles for functional alignment of human embryonic stem cells and their cardiac derivatives. Adv Mater 23, 5785-5791.
32. Chen-Izu et al. 2015
33. Chi KR (2013). Revolution dawning in cardiotoxicity testing. Nat Rev Drug Discov 12, 565-567.
34. Christie GR, Nielsen PMF, Blackett SA, Bradley CP & Hunter PJ (2009). FieldML: concepts and implementation. Philos Trans A Math Phys Eng Sci 367, 1869-1884.
35. Clancy CE & Rudy Y (1999). Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature 400, 566-569.
36. Clancy CE, Tateyama M & Kass RS (2002). Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome. J Clin Invest 110, 1251-1262.
37. + channels: an original mechanism of arrhythmia. Circulation 107, 2233-2237.
38. Coronel R, Lau DH, Sosunov EA, Janse MJ, Danilo P Jr, Anyukhovsky EP, Wilms-Schopman FJ, Opthof T, Shlapakova IN, Ozgen N, Prestia K, Kryukova Y, Cohen IS, Robinson RB & Rosen MR (2010). Cardiac expression of skeletal muscle sodium channels increases longitudinal conduction velocity in the canine 1-week myocardial infarction. Heart Rhythm 7, 1104-1110.
39. + transport in the normal and failing heart - remember the balance. J Mol Cell Cardiol 61, 2-10.
40. + concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation 105, 2543-2548.
41. 2+ sensors. Circ Res 115, 339-347.
42. + channels and drug-acquired long QT syndrome. Therapie 55, 185-193.
43. 2+ currents in cells that survived in the epicardial border zone of canine healed infarcted heart. Am J Physiol Heart Circ Physiol 287, H1046-H1054.
44. +] in ventricular myocytes. Am J Physiol Heart Circ Physiol 277, H1817-H1822.
45. i overloaded cardiac myocytes: a simulation study. Biophys J 78, 2392-2404.
46. Gaudron P, Kugler I, Hu K, Bauer W, Eilles C & Ertl G (2001). Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact. J Am Coll Cardiol 38, 33-40.
47. Glitsch HG ( 2001). Electrophysiology of the sodium-potassium-ATPase in cardiac cells. Physiol Rev 81, 1791-1826.
48. Goldberger JJ, Basu A, Boineau R, Buxton AE, Cain ME, Canty JM Jr, Chen PS, Chugh SS, Costantini O, Exner DV, Kadish AH, Lee B, Lloyd-Jones D, Moss AJ, Myerburg RJ, Olgin JE, Passman R, Stevenson WG, Tomaselli GF, Zareba W, Zipes DP & Zoloth L (2014). Risk stratification for sudden cardiac death: a plan for the future. Circulation 129, 516-526.
49. Grandi E, Pasqualini FS & Bers DM (2010). A novel computational model of the human ventricular action potential and Ca transient. J Mol Cell Cardiol 48, 112-121.
50. Haigney MC, Lakatta EG, Stern MD & Silverman HS (1994). Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation 90, 391-399.
51. Hale SL, Shryock JC, Belardinelli L, Sweeney M & Kloner RA (2008). Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol 44, 954-967.
52. Herren AW, Bers DM & Grandi E (2013). Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias. Am J Physiol Heart Circ Physiol 305, H431-H445.
53. Hilgemann D, Nagel G & Gadsby DC (1991). Na/K pump currents in giant membrane patches excised from ventricular myocytes. In The Sodium Pump: Recent Developments, eds. De Weer P & Kaplan JH, pp. 543-547. Rockefeller University Press, New York.
54. Hoeker GS, Katra RP, Wilson LD, Plummer BN & Laurita KR (2009). Spontaneous calcium release in tissue from the failing canine heart. Am J Physiol Heart Circ Physiol 297, H1235-H1242.
55. + current during cardiac action potential and its contribution to afterdepolarizations. J Mol Cell Cardiol 64, 59-68.
56. Hulot JS, Stillitano F, Salem JE, Kovacic JC, Fuster V & Hajjar RJ (2014). Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther 5, 1.
57. Na remodeling after myocardial infarction: insights from mathematical modeling. J Mol Cell Cardiol 45, 420-428.
58. Janse MJ & Wit AL (1989). Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69, 1049-1169.
59. 2+ current. Circ Res 64, 977-990.
60. Jian Z, Han H, Zhang T, Puglisi J, Izu LT, Shaw JA, Onofiok E, Erickson JR, Chen YJ, Horvath B, Shimkunas R, Xiao W, Li Y, Pan T, Chan J, Banyasz T, Tardiff JC, Chiamvimonvat N, Bers DM, Lam KS & Chen-Izu Y (2014). Mechanochemotransduction during cardiomyocyte contraction is mediated by localized nitric oxide signaling. Sci Signal 7, ra27.
61. + increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation 121, 1606-1613.
62. 2+ influx in cardiac myocytes. Circulation 122, 2273-2280.
63. Kondo RP, Wang SY, John SA, Weiss JN & Goldhaber JI (2000). Metabolic inhibition activates a non-selective current through connexin hemichannels in isolated ventricular myocytes. J Mol Cell Cardiol 32, 1859-1872.
64. Kr channels and drug-induced prolongation of cardiac repolarization. J Physiol 586, 2961-2973.
65. Lederer WJ, Hagen BM & Zhao G (2012). Cell biology. Superresolution subspace signaling. Science 336, 546-547.
66. Leem CH, Lagadic-Gossmann D & Vaughan-Jones RD (1999). Characterization of intracellular pH regulation in the guinea-pig ventricular myocyte. J Physiol 517, 159-180.
67. + current blockers. Am J Physiol Heart Circ Physiol 269, H533-H540.
68. Li L, Louch WE, Niederer SA, Aronsen JM, Christensen G, Sejersted OM & Smith NP (2012). Sodium accumulation in SERCA knockout-induced heart failure. Biophys J 102, 2039-2048.
69. Liang P, Lan F, Lee AS, Gong T, Sanchez-Freire V, Wang Y, Diecke S, Sallam K, Knowles JW, Wang PJ, Nguyen PK, Bers DM, Robbins RC & Wu JC (2013). Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 127, 1677-1691.
70. Liu T, Brown DA & O'Rourke B (2010). Role of mitochondrial dysfunction in cardiac glycoside toxicity. J Mol Cell Cardiol 49, 728-736.
71. 2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res 103, 279-288.
72. 2+ exchange prevents sudden death in a guinea pig model of heart failure. Circ Res 115, 44-54.
73. Louch WE, Hougen K, Mørk HK, Swift F, Aronsen JM, Sjaastad I, Reims HM, Roald B, Andersson KB, Christensen G & Sejersted OM (2010). Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout. J Physiol 588, 465-478.
74. Louch WE, Stokke MK, Sjaastad I, Christensen G & Sejersted OM (2012). No rest for the weary: diastolic calcium homeostasis in the normal and failing myocardium. Physiology (Bethesda) 27, 308-323.
75. Lue WM & Boyden PA (1992). Abnormal electrical properties of myocytes from chronically infarcted canine heart. Alterations in V˙ max and the transient outward current. Circulation 85, 1175-1188.
76. 2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes. Circ Res 99, 172-182.
77. Maltsev VA, Sabbah HN, Higgins RS, Silverman N, Lesch M & Undrovinas AI (1998a). Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 98, 2545-2552.
78. 2+ transient in cardiomyocytes of dogs with chronic heart failure. Cell Mol Life Sci 54, 597-605.
79. Maltsev VA, Silverman N, Sabbah HN & Undrovinas AI (2007). Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur J Heart Fail 9, 219-227.
80. + current in human ventricular cardiomyocytes. Cardiovasc Res 69, 116-127.
81. Matsa E, Sallam K & Wu JC (2014). Cardiac stem cell biology: glimpse of the past, present, and future. Circ Res 114, 21-27.
82. Mines G (1914). On circulating excitations in heart muscles and their possible relation to tachycardia and fibrillation. Trans R Soc Can 8, 43-53.
83. Mordwinkin NM, Lee AS & Wu JC (2013). Patient-specific stem cells and cardiovascular drug discovery. JAMA 310, 2039-2040.
84. Na-linked arrhythmias: in silico pharmacological screening. Circ Res 113, e50-61.
85. Moreno JD, Zhu ZI, Yang PC, Bankston JR, Jeng MT, Kang C, Wang L, Bayer JD, Christini DJ, Trayanova NA, Ripplinger CM, Kass RS & Clancy CE (2011). A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms. Sci Transl Med 3, 98ra83.
86. 2+-sensitivity? Biochemistry 39, 1316-1323.
87. Myles RC, Wang L, Kang C, Bers DM & Ripplinger CM (2012). Local β-adrenergic stimulation overcomes source-sink mismatch to generate focal arrhythmia. Circ Res 110, 1454-1464.
88. Neic A, Liebmann M, Hoetzl E, Mitchell L, Vigmond EJ, Haase G & Plank G (2012). Accelerating cardiac bidomain simulations using graphics processing units. IEEE Trans Biomed Eng 59, 2281-2290.
89. Nickel A, Kohlhaas M & Maack C (2014). Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol 73, 26-33.
90. Nikolic G, Bishop RL & Singh JB (1982). Sudden death recorded during Holter monitoring. Circulation 66, 218-225.
91. Nivala M, de Lange E, Rovetti R & Qu Z (2012). Computational modeling and numerical methods for spatiotemporal calcium cycling in ventricular myocytes. Front Physiol 3, 114.
92. 2+ exchange. Proc Natl Acad Sci USA 107, 436-441.
93. i and contractility in nonfailing and failing human myocardium. Circulation 106, 447-453.
94. Prosser BL, Ward CW & Lederer WJ (2011). X-ROS signaling: rapid mechano-chemo transduction in heart. Science 333, 1440-1445.
95. + currents in ventricular myocytes from the epicardial border zone of the infarcted heart. Circ Res 83, 431-440.
96. + currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ Res 81, 110-119.
97. Quinn TA, Granite S, Allessie MA, Antzelevitch C, Bollensdorff C, Bub G, Burton RAB, Cerbai E, Chen PS, Delmar M, DiFrancesco D, Earm YE, Efimov IR, Egger M, Entcheva E, Fink M, Fischmeister R, Franz MR, Garny A, Giles WR, Hannes T, Harding SE, Hunter PJ, Iribe G, Jalife J, Johnson CR, Kass RS, Kodama I, Koren G, Lord P, Markhasin VS, Matsuoka S, McCulloch AD, Mirams GR, Morley GE, Nattel S, Noble D, Olesen SP, Panfilov AV, Trayanova NA, Ravens U, Richard S, Rosenbaum DS, Rudy Y, Sachs F, Sachse FB, Saint DA, Schotten U, Solovyova O, Taggart P, Tung L, Varro A, Volders PG, Wang K, Weiss JN, Wettwer E, White E, Wilders R, Winslow RL & Kohl P (2011). Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): Standardised reporting for model reproducibility, interoperability, and data sharing. Prog Biophys Mol Biol 107, 4-10.
98. Rocha BM, Campos FO, Amorim RM, Plank G, dos Santos RW, Liebmann M & Haase G (2011). Accelerating cardiac excitation spread simulations using graphics processing units. Concurr Comp-Pract E 23, 708-720.
99. Sallam K, Kodo K & Wu JC (2014). Modeling inherited cardiac disorders. Circ J 78, 784-794.
100. Sato D, Bartos DC, Ginsburg KS & Bers DM (2014). Depolarization of cardiac membrane potential synchronizes calcium sparks and waves in tissue. Biophys J 107, 1313-1317.
101. Sato D & Clancy CE (2013). Cardiac electrophysiological dynamics from the cellular level to the organ level. Biomed Eng Comput Biol. 5, 69-75.
102. + preserves myocardial function at low heart rates in isolated myocardium from failing hearts. Eur J Heart Fail 8, 673-680.
103. 2+ exchanger protein levels in human heart failure. Circulation 99, 2105-2112.
104. Shattock et al. (2015).
105. Sicouri S, Antzelevitch D, Heilmann C & Antzelevitch C (1997). Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome. J Cardiovasc Electrophysiol 8, 1280-1290.
106. Song Y, Shryock JC, Wagner S, Maier LS & Belardinelli L (2006). Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther 318, 214-222.
107. Na in guinea pig ventricular myocytes. J Cardiovasc Pharmacol 44, 192-199.
108. + currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol 55, 2330-2342.
109. Starmer CF (2002). How antiarrhythmic drugs increase the rate of sudden cardiac death. Int J Bifurcat Chaos 12, 1953-1968.
110. Starmer CF, Biktashev VN, Romashko DN, Stepanov MR, Makarova ON & Krinsky VI (1993). Vulnerability in an excitable medium: analytical and numerical studies of initiating unidirectional propagation. Biophys J 65, 1775-1787.
111. Starmer CF, Lastra AA, Nesterenko VV & Grant AO (1991). Proarrhythmic response to sodium-channel blockade. Theoretical model and numerical experiments. Circulation 84, 1364-1377.
112. 2-isoform in heart failure. Cardiovasc Res 78, 71-78.
113. Szel T, Koncz I, Jost N, Baczko I, Husti Z, Virag L, Bussek A, Wettwer E, Ravens U, Papp JG & Varro A (2011). Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations. Eur J Pharmacol 662, 31-39.
114. Terrenoire C, Wang K, Tung KW, Chung WK, Pass RH, Lu JT, Jean JC, Omari A, Sampson KJ, Kotton DN, Keller G & Kass RS (2013). Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol 141, 61-72.
115. Trenor B, Gomis-Tena J, Cardona K, Romero L, Rajamani S, Belardinelli L, Giles WR & Saiz J (2013). In silico assessment of drug safety in human heart applied to late sodium current blockers. Channels (Austin) 7, 249-262.
116. Undrovinas A & Maltsev VA (2008). Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem 6, 348-359.
117. Undrovinas AI, Belardinelli L, Undrovinas NA & Sabbah HN (2006). Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol 17 (Suppl. 1), S169-S177.
118. + channel in normal and failing human myocardium. J Mol Cell Cardiol 34, 1477-1489.
119. Undrovinas AI, Maltsev VA & Sabbah HN (1999). Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci 55, 494-505.
120. 2+ accumulation in chronic heart failure. J Physiol Sci 60, 245-257.
121. + transport mechanisms in cardiac hypertrophy and failure. J Mol Cell Cardiol 35, 5-25.
122. Ver Donck L, Borgers M & Verdonck F (1993). Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc Res 27, 349-357.
123. + channels. J Clin Invest 116, 3127-3138.
124. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ & Veltri EP (1996). Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348, 7-12.
125. 2+ in the intact heart: ryanodine receptor refractoriness during alternans and fibrillation. Circ Res 114, 1410-1421.
126. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, Towbin JA & Keating MT (1995). SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80, 805-811.
127. Wasserstrom JA, Sharma R, O'Toole MJ, Zheng J, Kelly JE, Shryock J, Belardinelli L & Aistrup GL (2009). Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart. J Pharmacol Exp Ther 331, 382-391.
128. Weiss JN, Nivala M, Garfinkel A & Qu Z (2011). Alternans and arrhythmias: from cell to heart. Circ Res 108, 98-112.
129. Weiss JN, Qu Z, Chen P-S, Lin S-F, Karagueuzian HS, Hayashi H, Garfinkel A & Karma A (2005). The dynamics of cardiac fibrillation. Circulation 112, 1232-1240.
130. Weisser-Thomas J, Piacentino V 3rd, Gaughan JP, Margulies K & Houser SR (2003). Calcium entry via Na/Ca exchange during the action potential directly contributes to contraction of failing human ventricular myocytes. Cardiovasc Res 57, 974-985.
131. Wimalaratne SM, Halstead MDB, Lloyd CM, Crampin EJ & Nielsen PF (2009). Biophysical annotation and representation of CellML models. Bioinformatics 25, 2263-2270.
132. Wingo TL, Shah VN, Anderson ME, Lybrand TP, Chazin WJ & Balser JR (2004). An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability. Nat Struct Mol Biol 11, 219-225.
133. Kr inhibition on ventricular repolarization. Circulation 123, 1713-1720.
134. Wu L, Shryock JC, Song Y & Belardinelli L (2006). An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts. J Pharmacol Exp Ther 316, 718-726.
135. Xie Y, Sato D, Garfinkel A, Qu Z & Weiss JN (2010). So little source, so much sink: requirements for afterdepolarizations to propagate in tissue. Biophys J 99, 1408-1415.
136. + influx activates CaMKII in rat ventricular myocytes and N1325S mice. Am J Physiol Cell Physiol 301, C577-C586.
137. Zaza A, Belardinelli L & Shryock JC (2008). Pathophysiology and pharmacology of the cardiac 'late sodium current.' Pharmacol Ther 119, 326-339.
138. Zeng J & Rudy Y (1995). Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J 68, 949-964.
139. Zhou L, Solhjoo S, Millare B, Plank G, Abraham MR, Cortassa S, Trayanova N & O'Rourke B (2014). Effects of regional mitochondrial depolarization on electrical propagation: implications for arrhythmogenesis. Circ Arrhythm Electrophysiol 7, 143-151.